#Sanofi's long-running R&D #alliance with #Regeneron has gone up a gear with a #partnership – worth up to $8 billion – that spans four #newmedicines.
@pharmaphorum.bsky.social
@pharmaphorum.bsky.social#Sanofi's long-running R&D #alliance with #Regeneron has gone up a gear with a #partnership – worth up to $8 billion – that spans four #newmedicines.
@4040rec.bsky.social@pharmaphorum.bsky.social#Europe's top #pharma groups have called for #governments in the region to stop viewing #newmedicines as a #cost to suppress, rather than "one of the best #investments [they] can make."
@4040rec.bsky.social@4040rec.bsky.social@4040rec.bsky.social